Weiying Gu

Changzhou, 213003, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

Structural and functional characterization of Acyl-CoA Synthetase Long-Chain Family Member 3 (ACSL3) and its targeted inhibition by gramicidin in multiple myeloma.

Structural and functional characterization of Acyl-CoA Synthetase Long-Chain Family Member 3 (ACSL3) and its targeted inhibition by gramicidin in multiple myeloma.

Journal: International journal of biological macromolecules
Published: January 16, 2026

Risk factors for leukemic transformation in myeloproliferative neoplasms and prognostic factors in secondary acute myeloid leukemia: an exploratory analysis of the SEER database.

Risk factors for leukemic transformation in myeloproliferative neoplasms and prognostic factors in secondary acute myeloid leukemia: an exploratory analysis of the SEER database.

Journal: Annals of hematology
Published: October 14, 2025

A DLBCL Prognostic model superior to the IPI score: Mechanistic study and clinical validation based on RFC2- and RFC4-mediated DNA damage repair.

A DLBCL Prognostic model superior to the IPI score: Mechanistic study and clinical validation based on RFC2- and RFC4-mediated DNA damage repair.

Journal: Clinical and experimental medicine
Published: September 22, 2025

Tumor metabolic heterogeneity based on 18F-FDG PET/CT is a predictor of outcome in diffuse large B-cell lymphoma.

Tumor metabolic heterogeneity based on 18F-FDG PET/CT is a predictor of outcome in diffuse large B-cell lymphoma.

Journal: BMC cancer
Published: May 03, 2025

Outcomes of secondary primary malignancies among patients with diffuse large B-cell lymphoma.

Outcomes of secondary primary malignancies among patients with diffuse large B-cell lymphoma.

Journal: Discover oncology
Published: February 07, 2025

Metabolic tumour area: a novel prognostic indicator based on 18F-FDG PET/CT in patients with diffuse large B-cell lymphoma in the R-CHOP era.

Metabolic tumour area: a novel prognostic indicator based on 18F-FDG PET/CT in patients with diffuse large B-cell lymphoma in the R-CHOP era.

Journal: BMC cancer
Published: November 22, 2023

Dissemination feature based on PET/CT is a risk factor for diffuse large B cell lymphoma patients outcome.

Dissemination feature based on PET/CT is a risk factor for diffuse large B cell lymphoma patients outcome.

Journal: BMC cancer
Published: May 26, 2023

Effects of Decitabine Combined with Anlotinib on Proliferation and Apoptosis of Multiple Myeloma Cells

Effects of Decitabine Combined with Anlotinib on Proliferation and Apoptosis of Multiple Myeloma Cells

Journal: Zhongguo shi yan xue ye xue za zhi
Published: April 25, 2023

Corrigendum to "Bortezomib-resistant multiple myeloma patient-derived xenograft is sensitive to anti-CD47 therapy" [Leuk. Res. 122 (2022) 106949].

Corrigendum to "Bortezomib-resistant multiple myeloma patient-derived xenograft is sensitive to anti-CD47 therapy" [Leuk. Res. 122 (2022) 106949].

Journal: Leukemia research
Published: April 18, 2023

The Clinical Value of Neutrophil CD64 Index in Hematological Malignancies with Pulmonary Infection

The Clinical Value of Neutrophil CD64 Index in Hematological Malignancies with Pulmonary Infection

Journal: Zhongguo shi yan xue ye xue za zhi
Published: October 08, 2022

Altered serum lipid levels are associated with prognosis of diffuse large B cell lymphoma and influenced by utility of rituximab.

Altered serum lipid levels are associated with prognosis of diffuse large B cell lymphoma and influenced by utility of rituximab.

Journal: Annals of hematology
Published: August 30, 2022

Clinical significance of plasma PD-L1+ exosomes in the management of diffuse large B cell lymphoma.

Clinical significance of plasma PD-L1+ exosomes in the management of diffuse large B cell lymphoma.

Journal: Annals of hematology
Published: July 04, 2022
Showing 1-12 of 24

Last Updated: 09/26/2026